Sensitivity Assessment of Wilms Tumor Gene (WT1) Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with IDH1 Mutation and Recurrence Interval
Maher Kurdi,1 Nadeem Shafique Butt,2 Saleh Baeesa,3 Abudukadeer Kuerban,4 Yazid Maghrabi,5 Anas Bardeesi,5 Rothaina Saeedi,3 Badrah S Alghamdi,6 Ahmed I Lary,7 Fawaz Mohamed,1 Sahar Hakamy8 1Department of Pathology, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Kingdom of Saudi A...
Guardado en:
Autores principales: | Kurdi M, Butt NS, Baeesa S, Kuerban A, Maghrabi Y, Bardeesi A, Saeedi R, Alghamdi BS, Lary AI, Mohamed F, Hakamy S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5fce0df4fcc440a85ba02b865afaceb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
WT1 Expression as a Potential Biomarker of Malignancy in Canine Breast Tumor
por: Carranza-Martínez,Brisa D, et al.
Publicado: (2019) -
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
por: Iben Lyskjær, et al.
Publicado: (2021) -
PRMT5 regulates ovarian follicle development by facilitating Wt1 translation
por: Min Chen, et al.
Publicado: (2021) -
lncRNA DDGC participates in premature ovarian insufficiency through regulating RAD51 and WT1
por: Duan Li, et al.
Publicado: (2021) -
IDH1-mutated relapsed or refractory AML: current challenges and future prospects
por: Megías-Vericat JE, et al.
Publicado: (2019)